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INTRODUCTION 
Urinary stones (such as: kidney, urethra, bladder and 
urethra stones) are one of the most common and earliest 
known human diseases. After the urinary tract infection 
and prostate disease, it was the third most common 
problem of the urinary system. The prevalence of kidney 
stones during life is estimated about 1-15% which based 
on age, gender, race and geographical location it was 
differ. The prevalence of stones in men is 2-3 times more 
than women. The occurrence of stones before the age of 
20 is almost rare and its peak is in the 4th to 6th decades of 
life. In women, in the sixth decade of life, due to the 
incidence of menopause, another peak occurs.1 Urinary 
stones along with other risk factors such as diabetes 
mellitus and high blood pressure are the major causes of 
kidney damage and kidney failure which leading to 
dialysis and therefore its effective and timely treatment 
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Background: Urinary stones are one of the most common and earliest known human diseases. Extracorporeal shock 
wave lithotripsy (ESWL) is known as the most common method for treating urinary stones less than 20-25 mm. The 
aim of this study was to evaluation the success rate of ESWL in patients with urinary stones.  
Methods: In this cross-sectional descriptive study 200 patients with urinary stones between 7-25 mm which were 
candidates for lithotripsy, enrolled in the study. Patients with coagulation disorders, urinary or other organ 
transplantation, pregnant women, uncontrolled blood pressure patients, and those who are contraindicated for drug 
use have been excluded from the study. The process was carried out by an operator and by the Dornier Compact Delta 
II lithotriptor. Two weeks later, the patients were re-visited, and ultrasound was performed, and the success rate of 
stones was measured and recorded and classified in three groups complete response, partial response and failure in 
treatment. Collected data analysed by statistical methods in SPSS version 19.  
Results: Efficacy of Arian 101 lithotriptor in removing of renal stones, were found to be 74% complete response, 
25.5% partial response while 0.5% of subjects had no response. There was significant positive correlation between the 
size of stones before and after lithotripsy (r=0.49, p=0.001). In stones upper than 10 mm, the upper calices stones had 
100% complete response. Also, in stones lower than 10 mm, the upper calices stones had 100% complete response. 
Conclusions: The results showed that Dornier Compact Delta II lithotriptor has more efficacy in treatment of stones. 
In stones below 10 mm, the success rate of treatment was generally higher, especially in the upper calices stones and 
pelvic. In stones larger than 10 mm, the success rate was slightly lower, but in the case of upper calices stones, the 
complete response was 100%.  
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will reduce the complications and finally deal to 
significant reduction in the costs of the treatment.2 The 
most common urinary stones are calcium oxalate, 
calcium phosphate, magnesium ammonium phosphate, 
uric acid and cysteine stones.3 Most of the urinary stones 
appear at the onset of acute pain due to acute obstruction 
and upper urinary tract dilatation. Calices stones are often 
small, and multiplex and they pass by themselves. These 
stones can cause obstruction and renal colic, or they can 
to have produced periodic pain due to intermittent 
occlusion. This deep or vague pain is felt on the side or 
back and its severity varies. Pelvic stones larger than 1 
cm are commonly called UPJO (Ureteropelvic Junction 
Obstruction) which cause severe pain in CVA 
(Costovertebral Angle).4  
In recent years, major revolutions have been taken in the 
treatment of urinary stones. We can refer to the laser 
application, using percutaneous nephrolithotomy 
(PCNL), transurethral ureterolithotripsy (TUL) and 
finally ESWL that used without any anesthesia and no 
small incisions which urinary stones can be crushed 
within minutes.3 ESWL is known as the most common 
method for treating urinary stones (70%) and selective 
treatment for small urinary stones (7 to 25 mm).3 ESWL 
contra indication included pregnancy, uncorrected 
coagulation disorders, using anti platelet medications, 
distal to stones obstruction, urinary tract infections and 
renal artery or aorta aneurysms.4 The risks of ESWL 
included breaking the kidney vessels and staying scar, 
causing hypertension, producing brushite stones (a kind 
of stones that produce in the urinary epithelium damage) 
and perirenal hematoma are significantly less than 
invasive methods such as Percutaneous Nephrolithotomy 
(PCNL) and surgery. If all ESWLs were successful, these 
dangers were not significant but all of them not 
successful. So, with the right choice of patients with a 
high success rate for lithotripsy it is possible to reduce 
these risks without any impose extra costs and doing non-
important process for the patient.5 Over the past two 
decades, several types of lithotripsy have been marketed 
witch their success varies depending on the location and 
size of the stones. The success rate of these methods in 
stones smaller than 20-25 mm is about 70 to 97 percent.4,6 
Electrohydraulic crusher have advantages such as large 
focal area, maximum pressure is almost high and 
adjustable spindle t. Piezoelectric crusher have many 
advantages includes longer life spans, long-term 
performance and less irritation for the patient and allow 
shock waves to be given at different frequencies. 
Electromagnetic crusher have long lifetime, long lasting 
performance, large and continuing energy rating.7-9 
Several studies have been carried out on the efficacy of 
various ESWL such as sonolite, Litostear, Dornier and 
Arian 101 lithotriptor.6-10 Because of non-study about the 
performance of the Component Delta II lithotripter on 
different stones, this study was aimed at investigating the 
evaluation the success rate of extra corporal shock wave 
lithotripsy (ESWL) in patients with urinary stones.  
METHODS 
This prospective cross sectional descriptive was 
conducted on 200 people with urinary stones between 7-
25 mm who were candidate for lithotripsy in the first six 
months of 2017 enrolled the study, after taking informed 
consent.  
Exclusion criteria 
• Patients with coagulation disorders,  
• Urinary tract infection or other organs,  
• Pregnant women,  
• Uncontrolled blood pressure patients and  
• People who oppose drug use. 
Designing process 
The process was carried out by an operator and by the 
Dornier Compact Delta IIcrusher machine. After 
preparing the patient and performing the stone crushing 
process, the individual was under supervision for up to 2 
hours. Patients in the absence of a specific problem, were 
discharged with a diuretic drug, analgesic and if 
necessary an antibiotic. Two weeks later the patients 
were revisited, and sonography was performed, and the 
success rate of lithotripsy based on change in the size of 
the stone was measured and recorded. The complete 
cleaning of the urinary system or the remaining 4 mm 
stone or less was considered as a complete success and 
the presence of a stone larger than 4 mm and smaller than 
the original stone was considered as a partial success and 
failure to break the stone as a failure.  
Data collection and statistical analysis  
Patients' information was collected in a checklist 
containing age, sex, weight, job, history of drug use, 
kidney stone history, history of urinary tract infection, 
family history of stones, smoking and collected data 
analyzed by statistical methods in SPSS version 19. 
RESULTS 
Of the 196 people, 128 (65.3%) were male and 68 
(34.7%) were female (Table 1).  
Table 1: Characteristics of study patients. 
Mean±SD N (%) Variables 
9945.7±150 
94 (51.6) <7500 
WBC 
88 (48.4) >7500 
14.3±2.3 
86 (44) <14 
HG 
110 (56) >14 
1.14±0.2 
85 (43.5) <1.04 
CR 
111 (56.5) >1.04 
43.6±7.1 Age 
Sex                       
68 (34.7) Female 
128 (65.3) Male 
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Table 2: Location of stone. 
% n Location of stone % n Location of stone 
1.5 3 Right middle and lower calices 9.7 19 Left pelvic 
7.1 14 Left lower calices 14.8 29 right pelvic 
2 4 Right upper calices 16.8 33 Right urethra  
0.5 1 Pelvic and Left lower calices 4.1 8 Right UPJ 
0.5 1 Left pelvic and UPJ 12.8 25 Left urethra 
0.5 1 Right lower calices and urethra 3.6 7 Left renal sinus 
1.5 3 left middle calices 7.7 15 Left UPJ 
1 2 Right middle urethra 4.6 9 Right middle calices 
1 2 Right renal sinus 2 4 Right middle urethra 
100 196 Total  
2 4 Left upper calices 
6.1 12 Right lower calices 
 
The right urethra with 16.8% and then right pelvic with 
14.8% was in first and second most location for stones 
(Table 2). The average primary stone size is 12.98 mm. 
Of the primary stones, 32.7% had a size less than 10 mm 
(Figure 1).  
 
Figure 1: The first size of stones in study patients. 
Of all patients, 31.4% had mild hydronephrosis and 
30.9% moderate hydronephrosis. 33.5% had no 
hydronephrosis and 4.1% had severe hydronephrosis. 
41.3% of patients had kidney stones on the other side. 34 
(17.3%) of all patients, had kidney cysts. The average 
size of the stone after the crushing was 2.90 mm.74% of 
the stone after the lithotripsy had a size less than 4 mm 
and 26% had size more than 4 mm. Of the 45 people who 
needed to the second lithotripsy, 29 (64.4%) attempted to 
the second lithotripsy and 16 (35.6%) not participated in 
the second crusher. Of all patients, 19.9% had pain after 
the last lithotripsy. The average size of the primary stone 
before the lithotripsy was 12.98±4.62 and after the 
lithotripsy this average reach to 2.9±4.3 mm which was 
statistically significant (Table 3). 
Of all patients, 74% (145 people) had complete success 
of ESWL that of them, 113 (80%) had complete response 
and 32 people (20%) had partial response with the 
remaining stone smaller than 4 mm (Figure 2). In other 
words aging increases the size of the urinary system 
stones.  
 
Figure 2: The success rate of lithotripsy in patients. 
The results showed that the size of stone before 
lithotripsy was significantly different between men and 
women and the gender is effective in the size of the stone. 
Also, authors could say that the size of the stone before 
lithotripsy increases the size of the stone after the 
lithotripsy (Figure 3).  
 
Figure 3: The correlation between two sized after and 
before lithotripsy. 
33%
61%
6%
< 10 mm 10--20  mm > 20 mm
74%
26%
complete response partial response
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Table 3: The changes in the size of stones (mm) before 
and after lithotripsy. 
Tone size n mean±SD p-value 
Before lithotripsy 196 12.98±4.62 
0.001 
After lithotripsy 196 2.9±4.3 
Family history of stones, blood creatinine, white blood 
cells, number of shocks and the existence of stones on the 
other side hadn’t affect on the size of the formed stones 
and the rate of successful in patients with urinary system 
stones. The results showed that blood hemoglobin and the 
presence of cyst can affect the size of the stone before 
and after the lithotripsy. In fact, an increase in blood 
hemoglobin and the presence of a cyst causes an increase 
in the size of the stone before lithotripsy.  
DISCUSSION 
The average age of patients was 43.7 years compared to 
other studies conducted in this field that the difference 
could be related to the lifestyle and residence place of the 
patients. Also, the relationship between age and treatment 
results wasn’t statistically significant.11-14  
In the present study, 65% of patients were men and 35% 
were women and the gender of the patients was not 
related to the success rate of the lithotripsy. These results 
are in line with other studies.15-19 In the present study, 
31% had stone in proximal urethra and 27% in the pelvic 
and 18% in lower calices which in terms of distribution 
of stone formation was in line with other studies.20-22 In 
the present study, the average shock exposure was 3900 
and in stones below 10 mm the stones in the upper calices 
were 100% successful while 66 % of the middle calices 
stones were completed and 16% had partial response and 
16% had failure in treatment. 92% of lower calices stones 
had complete treatment and 8% had partial treatment. 
78% of the stones in primary renter had complete and 
11% had partial and 11% were unsuccessfully treated. In 
the pelvic region, 82% of the stones were completely 
treated and 18% partially. In the UPJ stones, 85% had 
complete treatment and 15% had partial treatment and the 
difference was statistically significant (P=0.001). The 
results of this study were in line with other studies.20-23 
In stones over 10 mm, the upper calices stones had 100% 
complete treatment. In the case of middle calices stones, 
66% of stones were fully treated and 33% were treated 
partially. In the lower calices region, 60% of the stones 
were treated as complete treatments and 34% were 
treated partially and 6% were defective treatment. In 
primary urethra stones, 68% had complete treatment 
while 29.5% were partially treated and 2.5% treated 
defectively. 72% of pelvic stones were fully treated and 
28% were treated partially. Of UPJ stones, 73% 
complete, 20% partial and 7% also had a treatment 
failure. The difference between the success rate of ESWL 
in stones over 10 mm based on the stone formation 
location was statistically significant (P=0.008). 
CONCLUSION 
The results showed that, the rate of success in the free 
from the stone of the urinary system is as dependent on 
the size and the formation location of the stone. In stones 
below 10 mm, the success rate of treatment was generally 
higher especially in the upper calices and pelvis. In stones 
above 10 mm, the success rate was slightly lower but in 
the case of upper calices stones in both groups stones 
were fully treated with 100%. The results showed that the 
gender and age of the patients did not correlate with the 
success rate of the treatment. It is suggested that similar 
studies be carried out in this area with larger sample size 
in the future. From the limitations of this study authors 
can mention the limitations of similar studies sources in 
relation to the association between the success rate of 
lithotripsy with the cyst rate, hydronephrosis and pain in 
patients after lithotripsy and limiting access to patients in 
the second visit. 
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